Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,014.25
2,583.77
1,691.32
3,585.84
3,340.25
2,878.81
2,373.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,014.25
2,583.77
1,691.32
3,585.84
3,340.25
2,878.81
2,373.94
Raw Material Cost
880.21
795.83
503.81
488.19
381.11
280.42
215.26
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.53
1.35
2.38
4.30
3.83
3.40
1.46
Selling and Distribution Expenses
1,334.80
1,122.24
1,305.48
1,266.98
1,151.05
1,042.94
932.04
Other Expenses
49.59
45.77
51.78
43.24
38.69
22.29
13.40
Total Expenditure (Excl Depreciation)
2,711.42
2,377.11
2,329.45
2,191.83
1,922.90
1,549.68
1,282.72
Operating Profit (PBDIT) excl Other Income
302.8
206.70000000000002
-638.1
1394
1417.4
1329.1
1091.2
Other Income
184.63
157.92
217.16
363.74
77.24
49.35
37.32
Operating Profit (PBDIT)
739.22
564.98
-256.42
1,941.39
1,653.46
1,495.90
1,152.38
Interest
0.53
1.35
2.38
4.30
3.83
3.40
1.46
Exceptional Items
150.92
-30.46
-121.57
-54.45
-42.77
22.39
-10.01
Gross Profit (PBDT)
2,134.04
1,787.95
1,187.50
3,097.65
2,959.14
2,598.38
2,158.68
Depreciation
259.22
227.03
202.11
186.62
161.39
117.43
27.39
Profit Before Tax
630.39
306.14
-582.47
1,696.01
1,445.47
1,397.47
1,113.52
Tax
15.72
-34.09
-142.96
243.26
214.76
230.19
179.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
614.66
340.07
-439.52
1,452.75
1,230.71
1,167.28
933.97
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
614.66
340.07
-439.52
1,452.75
1,230.71
1,167.28
933.97
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.00
0.16
-0.00
-0.00
-0.00
-0.00
-0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
614.66
340.23
-439.52
1,452.75
1,230.71
1,167.28
933.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,054.47
10,742.51
9,585.80
10,167.30
8,938.52
5,470.96
4,270.86
Earnings per share (EPS)
1.04
0.6
-0.78
2.59
2.19
2.08
1.66
Diluted Earnings per share
1.04
0.6
-0.78
2.59
2.19
2.08
1.66
Operating Profit Margin (Excl OI)
9.8%
6.97%
-39.95%
38.79%
42.36%
46.17%
45.82%
Gross Profit Margin
29.51%
20.64%
-22.49%
52.5%
48.11%
52.62%
48.06%
PAT Margin
20.39%
13.16%
-25.99%
40.51%
36.84%
40.55%
39.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 16.66% vs 52.77% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 80.69% vs 177.41% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 36.23% vs 185.96% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -64.29% vs -41.67% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Gan & Lee Pharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
3,014.25
0
3,014.25
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,014.25
0
3,014.25
Raw Material Cost
880.21
0
880.21
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.53
0
0.53
Selling and Distribution Expenses
1,334.80
0
1,334.80
Other Expenses
49.59
0.00
49.59
Total Expenditure (Excl Depreciation)
2,711.42
0
2,711.42
Operating Profit (PBDIT) excl Other Income
302.83
0.00
302.83
Other Income
184.63
0
184.63
Operating Profit (PBDIT)
739.22
0
739.22
Interest
0.53
0
0.53
Exceptional Items
150.92
0
150.92
Gross Profit (PBDT)
2,134.04
0
2,134.04
Depreciation
259.22
0
259.22
Profit Before Tax
630.39
0
630.39
Tax
15.72
0
15.72
Provisions and contingencies
0
0
0.00
Profit After Tax
614.66
0
614.66
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
614.66
0
614.66
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.00
0
-0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
614.66
0
614.66
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,054.47
0
11,054.47
Earnings per share (EPS)
1.04
0
1.04
Diluted Earnings per share
1.04
0
1.04
Operating Profit Margin (Excl OI)
9.80%
0%
0.00
9.80%
Gross Profit Margin
29.51%
0%
0.00
29.51%
PAT Margin
20.39%
0%
0.00
20.39%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 301.42 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 16.66% vs 52.77% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 61.47 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 80.69% vs 177.41% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 55.46 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 36.23% vs 185.96% in Dec 2023
Annual - Interest
Interest 0.05 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -64.29% vs -41.67% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.80%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






